The neuropsychiatry of Prader-Willi syndrome

Current Opinion in Psychiatry

Volumn 11, Issue 5, 1998, Pages 519-522

  Dykens, Elisabeth M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PSYCHOTROPIC AGENT;

BEHAVIOR DISORDER; CLINICAL FEATURE; DIET THERAPY; GENOTYPE; HUMAN; HYPERPHAGIA; MENTAL DISEASE; NEUROPSYCHIATRY; PHENOTYPE; PRADER WILLI SYNDROME; SHORT STATURE; SHORT SURVEY;

EID: 0031664507     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199809000-00016     Document Type: Short Survey

References (35)

1. Dykens EM, Cassidy SM. Prader-Willi syndrome: genetic, behavioral, and treatment issues. Child Adolesc Psychiatr Clin North Am 1996; 5:913-928.
2. Dykens EM, Cassidy SB. Prader-Willi syndrome: four decades of progress. In: Goldstein S, Reynolds C (editors). Neurodevelopmental and genetic disorders in children. New York: Guilford Press; (in press).
3. Dykens EM, Kasari C. Maladaptive behavior in Prader-Willi syndrome, Down syndrome and non-specific mental retardation. Am J Mental Retard 1997; 102:228-237. This study examines the distinctiveness of the Prader-Willi behavioral phenotype.
4. Dykens EM, Smith ACM. Distinctiveness and correlates of maladaptive behavior in children and adolescents with Smith-Magenis syndrome. 1998; submitted.
5. Dykens EM. Anxiety and fears in Williams syndrome. 1998; submitted.
6. Dykens EM, Leckman JF, Cassidy SB. Obsessions and compulsions in Prader-Willi syndrome. J Child Psychol Psychiatry 1996; 37:995-1002.
7. State MW, Dykens EM, Rosner BA, Martin A, King BH. Obsessive-compulsive symptoms in Prader-Willi syndrome and 'Prader-Willi-like' patients. 1998; submitted.
8. Leckman JF, Goodman WK, North WJ, Chappell PB, Price LH, Pauls DL, et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder: comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry 1994; 51:782-792.
9. Leckman JF, Goodman WK, North WJ, Chappell PB, Price LH, Pauls DL, et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology 1994; 19:723-749.
10. Swaab DF. Prader-Willi syndrome and the hypothalamus. Acta Paediatr Suppl 1997; 423:50-54.
11. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 1995; 80:573-579.
12. Martin A, State MW, Kaye W, North WG, Leckman JF. Elevated cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report. 1998; submitted.
13. Clarke DJ. Prader-Willi syndrome and psychoses. Br J Psychiatry 1993; 163:680-684.
14. Clarke DJ, Webb T, Bachmann-Clarke JP. Prader-Willi syndrome and psychotic symptoms: report of a further case. Irish J Psychol Med 1995; 12:27-29.
15. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenen SB, Crawford JD. Deletion of chromosome 15 as a cause of Prader-Willi syndrome. New Eng J Med 1981; 304:325-329.
16. Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature 1989; 16:281-285.
17. Cassidy SB, Forsythe M, Heeger S, Nichols RD, Schork N, Benn P, Schwartz S. Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet 1997; 68:433-440.
18. Gunay-Aygun M, Heeger S, Schwartz S, Cassidy SB. Delayed diagnosis in patients with Prader-Willi syndrome due to maternal uniparental disomy 15. Am J Med Genet 1997; 71:106-110. This study summarizes certain differences in the physical features of persons with paternal deletion versus maternal UPD, which may contribute to later diagnoses in UPD cases.
19. Gillessen-Kaesbach G, Robinson W, Lohmann D, Kaya-Westerloh S, Passarge E, Horsthemke B. Genotype-phenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome. Hum Genet 1995; 96:638-643.
20. Dykens EM, Cassidy SB, King BH. Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy. Am J Mental Retard (in press).
21. Smith A, Marks R, Haan E, Dixon J, Trent RJ. Clinical features in four patients with Angelman syndrome resulting from paternal uniparental disomy. J Med Genet 1997; 24:426-429. This article reviews all cases reported to date, including four new ones, of Angelman's syndrome due to paternal UPD, and compares them with cases with maternal deletion.
22. Hauffa BP. One year results of growth hormone treatment of short stature in Prader-Willi syndrome. Acta Paediatr Suppl 1997; 423:63-65.
23. Lindgren AC, Hagenas L, Muller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzen EM. Effects of growth hormone treatment on growth and body composition in Prader-Willi syndrome: a preliminary report. The Swedish National Growth Hormone Advisory Panel. Acta Paediatr Suppl 1997; 423:423-462. This research documents the effects of growth hormone treatment in a sizeable cohort of children with PWS.
24. Benjamin E, Buot-Smith T. Naltrexone and fluoxetine in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 1993; 32:870-873.
25. Hellings JA, Warnock JL. Self-injurious behaviors and serotonin in Prader-Willi syndrome. Psychopharmacol Bull 1994; 30:245-250.
26. Bhargava SA, Putman PE, Kocoshis SA, Rowe M, Hanchett JM. Rectal bleeding in Prader-Willi syndrome. Pediatrics 1996; 97:265-267.
27. King BH. Self-injury in people with mental retardation. Curr Opin Psychiatry 1998; 11:523-526.
28. Ebert MH, Schmidt DE, Thompson T, Butler MG. Elevated plasma gamma-aminobutyric acid (GABA) levels in individuals with either Prader-Willi syndrome or Angelman syndrome. Journal of Neuropsychiatry and Clinical Neurosciences 1997; 9:75-80. This study is the first to document aberrant γ-aminobutyric acid levels both in PWS and in Angelman's syndrome.
29. Hodapp RM, Dykens EM, Massino LL. Families of children with Prader-Willi syndrome: stress-support and relations to child characteristics. J Autism Dev Disord 1997; 27:11-24.
30. Sarimski K. Behavioural phenotypes and family stress in three mental retardation syndromes. Eur Child Adolesc Psychiatry 1997; 6:26-31.
31. Fieldstone A, Zipf WB, Schwartz HC, Berntson GG. Food preferences in Prader-Willi syndrome, normal weight and obese controls. Int J Obes Related Metab Disord 1997; 21:1046-1052.
32. Joseph B, Overmier JB, Thompson T. Food-and nonfood-related differential learning outcomes in equivalence learning by adults with Prader-Willi syndrome. Am J Mental Retard 1997; 101:374-386.
33. Dykens EM, Goff BJ, Hodapp RM, Davis L, Devanzo P, Moss F, et al. Eating themselves to death: have 'personal rights' gone too far in treating people with Prader-Willi syndrome? Mental Retard 1997; 35:312-314.
34. Dykens EM, Hodapp RM. Treatment issues in genetic mental retardation syndromes. Professional Psychol Res Pract 1997; 28:263-270. This paper provides an overview of salient treatment recommendations in PWS and other mental retardation syndromes.
35. Sutcliffe JS, Han M, Christian SL, Ledbetter DH. Neuronally-expressed necdin gene: an imprinted candidate gene in Prader-Willi syndrome. Lancet 1997; 350:1520-1521. This research identifies another maternally imprinted gene in the Prader-Willi critical region.